AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Specific mutation in RhoA gene is associated with T-cell lymphoma cancer cells

Summary
Adolfo Ferrando, M.D., Ph.D.
Technology Benefits
Current treatments are primarily chemotherapy combinations with no gene-specific targetsNovel allele associated with T-cell lymphoma provides a new target for drug therapiesHigh levels of Rho are associated with malignant cellsPatent information:Patent Pending
Technology Application
Clinical diagnostic for a patient's risk of T-cell lymphoma and sensitivity to RhoA inhibitorsResearch tool for better understanding of T-cell lymphomaPotential clinical target for new T-cell lymphoma therapies
Detailed Technology Description
Adolfo Ferrando, M.D., Ph.D.
*Abstract
None
*Inquiry
Peter GolikovColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
*IR
CU13221
*Principal Investigator
Country/Region
USA

For more information, please click Here
Mobile Device